Related references
Note: Only part of the references are listed.Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation
Stephen J. Halpin et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
Robert L. Gottlieb et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
Lionel Piroth et al.
LANCET RESPIRATORY MEDICINE (2021)
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Daming Zhou et al.
CELL (2021)
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Rita E. Chen et al.
NATURE MEDICINE (2021)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China
Ruchong Chen et al.
CHEST (2020)
COVID-19 and Cancer: a Comprehensive Review
Rohit Gosain et al.
CURRENT ONCOLOGY REPORTS (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019-COVID-NET, 14 States, March 1-30, 2020
Shikha Garg et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Severe Covid-19
David A. Berlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 and comorbidities: Deleterious impact on infected patients
Hasan Ejaz et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)
Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19-COVID-NET, 14 States, March 1-July 25, 2020
Lindsay Kim et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Persistent Symptoms in Patients After Acute COVID-19
Angelo Carfi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
A. B. Cavalcanti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Long-term Health Consequences of COVID-19
Carlos del Rio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
Donald J. Benton et al.
NATURE (2020)
Risk for In-Hospital Complications Associated with COVID-19 and Influenza - Veterans Health Administration, United States, October 1, 2018-May 31, 2020
Jordan Cates et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis
Vignesh Chidambaram et al.
PLOS ONE (2020)
Monoclonal Antibodies for Emerging Infectious Diseases - Borrowing from History
Hilary D. Marston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)